Immunic (IMUX) Assets Average (2014 - 2026)

Immunic (IMUX) has 13 years of Assets Average data on file, last reported at $106.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 248.3% year-over-year to $106.9 million; the trailing twelve-month figure through Mar 2026 stood at $106.9 million (up 248.3% YoY), and the FY2025 full-year result was $32.5 million, down 31.78% from the prior year.
• Assets Average advanced to $106.9 million in Q1 2026, from $32.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $144.5 million in Q1 2022 to a low of $30.7 million in Q1 2025.
• A 5-year average of $86.1 million and a median of $79.2 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average slumped 61.26% in 2025 and surged 248.3% in 2026, its largest moves.
• Tracing IMUX's Assets Average over 5 years: stood at $124.4 million in 2022, then plunged by 51.26% to $60.6 million in 2023, then decreased by 12.9% to $52.8 million in 2024, then slumped by 38.7% to $32.4 million in 2025, then soared by 230.15% to $106.9 million in 2026.
• Business Quant data shows IMUX's Assets Average at $106.9 million in Q1 2026, $32.4 million in Q4 2025, and $51.1 million in Q3 2025.